Concepedia

Taku Fukuzawa

TF

10

Publications

769

Citations

10

H-Index

2002

Active since

Affiliations

Tokyo Institute of Technology(Current)

Chugai Pharma (United States)

Taku Fukuzawa is an author at Tokyo Institute of Technology specializing in medicine, cell biology, and molecular physiology.

Top concepts

Publications per year

2002–2019

10

Publications

10

Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice

Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 164 citations

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases

Taku Fukuzawa, Zenjiro Sampei, Kenta Haraya et al. · Scientific Reports · 2017 · 104 citations · Full text

, , +17

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models

M. Suzuki, Minako Takeda, A Kito et al. · Nutrition and Diabetes · 2014 · 97 citations · Full text

Tofogliflozin, a novel sodium–glucose co‐transporter 2 inhibitor, improves renal and pancreatic function in <i>db/db</i> mice

Takumi Nagata, Taku Fukuzawa, Minako Takeda et al. · British Journal of Pharmacology · 2013 · 87 citations · Full text

Cleavage of Ig-Hepta at a “SEA” Module and at a Conserved G Protein-coupled Receptor Proteolytic Site

Jumpei Abe, Taku Fukuzawa, Shigehisa Hirose · Journal of Biological Chemistry · 2002 · 73 citations · Full text

, , +21

Rows per page

1–5 of 10